Allianz Asset Management GmbH Boosts Stock Position in Avantor, Inc. $AVTR

Allianz Asset Management GmbH boosted its holdings in Avantor, Inc. (NYSE:AVTR) by 43.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,513 shares of the company’s stock after purchasing an additional 19,813 shares during the period. Allianz Asset Management GmbH’s holdings in Avantor were worth $882,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the company. Dodge & Cox raised its stake in shares of Avantor by 1.1% in the first quarter. Dodge & Cox now owns 100,262,723 shares of the company’s stock valued at $1,625,259,000 after buying an additional 1,116,953 shares during the period. Vanguard Group Inc. increased its stake in Avantor by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 64,952,926 shares of the company’s stock worth $1,052,887,000 after acquiring an additional 983,172 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Avantor by 1.5% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 41,969,199 shares of the company’s stock worth $680,321,000 after purchasing an additional 608,806 shares in the last quarter. 1832 Asset Management L.P. grew its holdings in shares of Avantor by 89.8% during the 1st quarter. 1832 Asset Management L.P. now owns 18,127,204 shares of the company’s stock valued at $293,842,000 after purchasing an additional 8,578,493 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its holdings in Avantor by 53.2% during the 1st quarter. The Manufacturers Life Insurance Company now owns 14,034,699 shares of the company’s stock valued at $227,502,000 after acquiring an additional 4,876,524 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Insider Transactions at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the transaction, the chief accounting officer directly owned 55,068 shares of the company’s stock, valued at approximately $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.20% of the company’s stock.

Avantor Stock Down 0.2%

Shares of NYSE:AVTR opened at $15.44 on Monday. The company has a current ratio of 0.98, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $10.52 billion, a price-to-earnings ratio of 15.59, a PEG ratio of 5.03 and a beta of 0.98. Avantor, Inc. has a 12-month low of $10.82 and a 12-month high of $23.70. The stock has a fifty day simple moving average of $13.33 and a two-hundred day simple moving average of $13.34.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%.The firm’s quarterly revenue was down 1.1% on a year-over-year basis. During the same period last year, the firm posted $0.25 earnings per share. On average, research analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Morgan Stanley lowered their target price on Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, August 4th. Wells Fargo & Company lowered their target price on Avantor from $19.00 to $16.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Royal Bank Of Canada lowered their target price on Avantor from $20.00 to $17.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Barclays raised their target price on Avantor from $13.00 to $15.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Finally, Evercore ISI lowered their target price on Avantor from $18.00 to $16.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $15.96.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.